Treating MS-CCSVI by cerebrospinal vein dilatation is medical science and practice
The basis for using venous angioplasty as a treatment for multiple sclerosis (MS), is the presumed pathophysiological mechanism of chronic cerebrospinal venous insufficiency (CCSVI). The concept of CCSVI, whether or not the presumed cause of MS, has not been generally accepted. No evidence has been found for the efficacy of angioplasty as a treatment for MS. Using venous angioplasty to treat MS (with presumed CCSVI) does not comply with established medical science and and medical practice.